High Tower Advisors, LLC Celldex Therapeutics, Inc. Transaction History

High Tower Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$20.5 - $37.33 $209,469 - $381,437	-10,218 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$27.64 - $39.32 $282,425 - $401,771	10,218 New	10,218 $350,000
Q4 2021 Feb 10, 2022	SELL	$35.68 - $56.27 $147,964 - $233,351	-4,147 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$28.95 - $55.99 $120,055 - $232,190	4,147 New	4,147 $225,000
Q4 2019 Feb 14, 2020	SELL	$2.11 - $2.8 $23,790 - $31,569	-11,275 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$2.05 - $2.75 $1,305 - $1,751	-637 Reduced 5.35%	11,275 $21,000
Q2 2019 Aug 13, 2019	BUY	$2.43 - $5.09 $28,946 - $60,632	11,912 New	11,912 $31,000

207

67.3M

1.69M

980K

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.32B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.